logo for Argos Therapeutics

Argos Therapeutics

Manufacturing · North Carolina, United States · 44 Employees

View Company Info for Free

About

Headquarters

4233 Technology Dr, Durham, North Carolina, 277...

Phone Number

(919) 287-6300

Revenue

<$5 Million

Stock Symbol

77A.BE

Industry

Manufacturing General Manufacturing

Who is Argos Therapeutics

Argos Therapeutics, Inc., an immuno-oncology company, focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on its proprietary technology platform, Arcelis. Its product candidates include rocapuldencel-T, which is in Phase III clinical trial for the treatment of metastatic renal cell carcinoma; and in Phase II clinical trial to treat early stage renal cell carcinoma and muscle invasive bladder cancer. The company also develops AGS-004, which is in Phase II clinical trials for the treatment of human immunodeficiency virus. The company was formerly known as Merix Bioscience, Inc. and changed its name to Argos Therapeutics, Inc. in October 2004. Argos Therapeutics, Inc. was founded in 1997 and is based in Durham, North...Read more

Argos Therapeutics's Social MediaPopular SearchesARGOS THERAPEUTICS IncArgos TherapeuticsDC Bio CorptherapeuticsArgosSIC Code 80,806NAICS Code 54,541Ticker FRA: 77A.BEShow more

Argos Therapeutics Org Chart

PhoneEmail
M. Winship

Vice President, Quality and Regulatory Affair...

PhoneEmail
Stephen Elliston

Vice President, Business Development

PhoneEmail

PhoneEmail

Similar Companies to Argos Therapeutics

  1. <25
    <$5M

    1

  2. 46
    <$5M

    2

  3. 30
    $10.1M

    3

  4. 29
    $8.9M

    4

  5. <25
    <$5M

    5

  6. 116
    $39.2M

    6

See more similar companies

Argos Therapeutics Tech Stack

A closer look at the technologies used by Argos Therapeutics

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Argos Therapeutics News & Media

Read more news

Frequently Asked Questions regarding Argos Therapeutics

Where is Argos Therapeutics located?
Argos Therapeutics's headquarters are located at 4233 Technology Dr, Durham, North Carolina, 27704, United States
What is Argos Therapeutics's phone number?
Argos Therapeutics's phone number is (919) 287-6300
What is Argos Therapeutics's stock symbol?
Argos Therapeutics's stock symbol is 77A.BE
What is Argos Therapeutics's official website?
Argos Therapeutics's official website is www.argostherapeutics.com
What is Argos Therapeutics's Revenue?
Argos Therapeutics's revenue is <$5 Million
What is Argos Therapeutics's SIC code?
Argos Therapeutics's SIC: 80,806
What is Argos Therapeutics's NAICS code?
Argos Therapeutics's NAICS: 54,541
How many employees does Argos Therapeutics have?
Argos Therapeutics has 44 employees
What industry does Argos Therapeutics belong to?
Argos Therapeutics is in the industry of: Manufacturing General, Manufacturing
What is Argos Therapeutics competition?
Argos Therapeutics top competitors include: Northwest Biotherapeutics, CEL-SCI, Checkmate Pharmaceuticals, BioMotiv
What technology does Argos Therapeutics use?
Some of the popular technologies that Argos Therapeutics uses are: WordPress.org, Drupal, PHP, New Relic Browser
How do I contact Argos Therapeutics?
Argos Therapeutics contact info: Phone number: (919) 287-6300 Website: www.argostherapeutics.com
What does Argos Therapeutics do?

Argos Therapeutics, Inc., an immuno-oncology company, focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on its proprietary technology platform, Arcelis. Its product candidates include rocapuldencel-T, whi... ch is in Phase III clinical trial for the treatment of metastatic renal cell carcinoma; and in Phase II clinical trial to treat early stage renal cell carcinoma and muscle invasive bladder cancer. The company also develops AGS-004, which is in Phase II clinical trials for the treatment of human immunodeficiency virus. The company was formerly known as Merix Bioscience, Inc. and changed its name to Argos Therapeutics, Inc. in October 2004. Argos Therapeutics, Inc. was founded in 1997 and is based in Durham, North...Read More

What are Argos Therapeutics social media links?
Argos Therapeutics Linkedin page Argos Therapeutics Twitter page Argos Therapeutics Facebook page
Is Argos Therapeutics a public company?
Yes, Argos Therapeutics is a public company and is traded under the symbol 77A.BE
See more information about Argos Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.